On November 26, 2026, Vivos Inc issued a common stock purchase warrant allowing the holder to purchase up to 2.5 million shares of Common Stock at a price equal to the Exercise Price through December 31, 2030. Financial relevance is indirect, indicating dilutive potential upon full exercise.